Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001137439-25-000528
Filing Date
2025-05-27
Accepted
2025-05-27 16:44:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 4586
  Complete submission text file 0001137439-25-000528.txt   5935
Mailing Address 55 PARK LANE LONDON X0 W1K 1NA
Business Address 55 PARK LANE LONDON X0 W1K 1NA 44 (0) 207 495 2379
OKYO Pharma Ltd (Subject) CIK: 0001849296 (see all company filings)

EIN.: 000000000
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94928 | Film No.: 25989379
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 6222 INDIANWOOD TR. BLOOMFIELD HILLS MI 48301
Business Address
Chernett Jorey (Filed by) CIK: 0002042077 (see all company filings)

Type: SCHEDULE 13G